No pain, no gain?

Article Abstract:

Pharmaceutical companies offering traditional opioid pain relievers are finding it difficult to penetrate the market, which could be one reason why opioid treatment speculation has not yet seen emotional price gains on the US stock markets. Investment guidelines include stocks to be wary of, such as Ligand Pharmaceuticals, and those that are an attractive speculation like Pain Therapeutics.

Pharmaceutical Preparation Manufacturing, Narcotic Analgesic Preparations, Complications and side effects, Opioids

---

Peptide leads new class of chronic pain drug

Article Abstract:

The European Commission approved the first peptide, Ziconotid, for chronic pain that paves the way for next generation of pain killers. Ziconotide specifically targets N-type calcium channels, which are crucial for transmitting pain signals from sensory neurons to the spinal cord and then to brain.

Europe, Government regulation, Science & research, Research, European Union. European Commission, Licensing, certification and accreditation, Peptides

---

More than meets the eyes?

Article Abstract:

Age-related molecular degeneration (AMD) is the prime cause of the blindness affecting 13-15 million people in the United States alone. About 500,000 new wet AMD cases are diagnosed worldwide each year.

Causes of, Blindness, Degeneration (Pathology)

Similar abstracts:

• Abstracts: Press races against bloggers for news. Profiles of healthcare & medical PR firms
• Abstracts: Global Hawk UAV readies for new sensors. Sirorsky claims safety edge in PRV bid. Northrop Grumman sees global hawk as 'computer'
• Abstracts: Northrop Grumman positioning unit for laser boom. Lockheed demonstrates night vision capability in F-16 centers
• Abstracts: The zinc finger nuclease monopoly. Mice with a human touch. The problem with potency
• Abstracts: New biotech oasis? Spanish wishful thinking towards biotech. BioXell: An Italian Biotech success story?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.